Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
26 Cards in this Set
- Front
- Back
3 pathways to pathogenesis as a result of a defective metabolic enzyme
|
loss of product
accumulation of substrate alternate pathway (diversion of substrate into a different pathway producing toxic effects) |
|
glactosemia
|
autosomal recessive
mutation in Gal-1-P uridyl transferase mutation of Gal-1P is toxic to liver and kidney conversion of built up galactose to galactitol is toxic to lungs and causes cateracts |
|
galactitol
|
in galactosemia, build up of galactose gets converted to galacititol which is toxic to lung and causes cateracts
|
|
Gal-1-phosphate
|
builds up in galacosemia, toxic to liver and kidney
|
|
galactosemia clinical
|
vomiting, diarrhea, hypoglycemia, acidosis, failure to thrive, jaundice, hepatomegaly, cateracts, hemolysis, mental retardation, ecoli sepsis
|
|
galactosemia diagnosis
|
screen for negative urine glucose oxidase
confirm with direct measurement of gal-1 PUT enzyme activity |
|
galactosemia treatment
|
eliminate galactose/lactose in diet
dietary restriction in heterozygote mother during pregnancy calcium suppliment |
|
tyrosinemia pathogenesis
|
auto rec
defect in fumyrlacetoacetate hydrolase (FAH) accumulation of maleylacetoacetate and fumarylacetoacetate = combine to succinylacetone succinylacetone blocks conversion of delta-ALA (aminolevunic acid) to prophobilinogen damage to liver, kidney, brain |
|
tyrosinemia clinical
|
hepatic - liver damage, cholestasis, cirrhosis, hepatocellular carcinoma
renal - tubular dysfunction: rickets, + others neurological crisis - parethesis, hypertension, teachcardia, progressive weakness -> paralysis, death |
|
tyrosinemia diagnosis
|
suspect in patients with liver issues + rickets, coagulopathy, neurological crisis
increase urine and blood succinylacetone decreased FAH in blood plasma tyrosine level USELESS |
|
tyrosinemia treatment
|
dietary restruction of phenylalanine and trosine
NTBC liver transplant |
|
hemochromatosis
|
excessive accumulation of iron, which deposits everywhere
hereditary or acquired hereditary form due to HFE gene on chromosome 6 |
|
hereditary hemochomatosis
|
HFE gene mutation on chr 6
most common mutation is C282Y more common in males overexpression of divalent metal iron transporter (DMT) -> too much absorption of iron - slow accumulation |
|
hemochromatosis clinical
|
bronzing of skin
diabetes from pancreas damage liver cancer from liver damage |
|
hemochromatosis diagnosis
|
increased serum iron, ferritin, TIBC
liver biopsy - hepatic iron >5600ug/g |
|
ferritin level and serum iron in hemochromatosis
|
both ferritin and serum iron increased
|
|
ferritin level and serum iron in acute infection
|
ferrtin increased, serum iron low
|
|
ferritin level and serum iron in anemia of chronic disease
|
ferritin is normal, decreased serum iron
|
|
ferritin level and serum iron in anemia
|
ferritin decreased, serum iron decreased
|
|
treatment of hemochromatosis
|
phlebotomy
|
|
wilson's disease pathogenesis
|
auto rec
mutation in ATP7B on chr 13 unable to excrete copper into bile - accumulation of Cu unable to make ceruloplasmin with copper - decrease Cu build up damages liver, basal ganglia, cornea, kidney, other tissues |
|
in the blood, copper is carried by
|
albumin to the liver
|
|
fate of copper in the body
|
incorporated to alpha2 globulin to form ceruloplasmin
|
|
wilson's disease clinical
|
kaiser fleischer rings, neuropsych disorider, cadiomyopathy, hepatitis, cirrhosis, fanconi syndrome, HEMOLYTIC ANEMIA, osteopenia
|
|
alpha1 anti-trypsin deficiency
|
auto rec
chr14 deficiency of protease inhibitor lung disease caused by inhibited action of proteinases liver disease caused by intracellular accumulation of defective alpha1AT increased risk of hepatocellular carcinoma |
|
alpha1 antitrypsin deficiency diagnosis
|
increased LFT
increased GGT A1AT level liver biopsy - giant cell hepatitis, cirrhosis, red hyaline globule on stain |